CD4 and neoplasm: In vivo studies showed that treatment with BB-NVs increased the proportion of CD3+CD4+ and CD3+CD8+ cells in tumor tissue and spleen and significantly increased the expression of anti-tumor cytokines TNF-α, IL-6, IL-10, and IFN-γ.